autoimmune diseases
-
Lilly India enters the autoimmune segment with Olumiant™, a new once-daily oral therapy for Rheumatoid Arthritis
Eli Lilly and Company (India) Pvt. Ltd. (“Lilly India”) announced the launch of Olumiant™ (baricitinib). This announcement is taking place…
Read More »